PDMR Dealing

RNS Number : 1045M

Oncimmune Holdings PLC

06 May 2020

 

Oncimmune Holdings plc

("Oncimmune" or the "Company")

PDMR Dealing

Oncimmune Holdings plc (AIM: ONC.L), a leader in the development, manufacture and commercialisation of personalised immunodiagnostics for the screening, detection and care of cancer, has been notified that Carsten Schroeder, PDMR and Non-Executive Director, has purchased 18,000 ordinary shares of £0.01 each in the Company ("Ordinary Shares") for 85 pence per share on 4 May 2020.

Following this transaction, Carsten has a total interest in the Company of 27,000 Ordinary Shares, representing approximately 0.04 per cent of the Company's issued Ordinary Share capital.    

This announcement, including the notification below, is made in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Carsten Schroeder
2	Reason for the notification
a)	Position/status	Non-Executive Director
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Oncimmune Holdings plc
b)	LEI	213800HCYIWT6YPI1I02
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Ordinary Shares of £0.01 each
	Identification code	ISIN: GB00BYQ94H38
b)	Nature of the transaction	Purchase of shares
c)	Price(s) and volume(s)
			Price	Volume
			£0.85	18,000
d)	Aggregated information
	- Aggregated volume	Same as above
	- Price
e)	Date of the transaction	4 May 2020
f)	Place of the transaction	London stock exchange, AIM

For further information:

Oncimmune Holdings plc

Ron Kirschner, General Counsel and Company Secretary

[e-mail]    

 

END

 

 

DSHKKABPOBKKQPK